Cystinuria: Failure of Captopril to Reduce Cystine Excretion-Reply
- 1 March 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 149 (3), 713-717
- https://doi.org/10.1001/archinte.1989.00390030153036
Abstract
In Reply.—We are most encouraged to see that our findings1 have prompted other investigators to research the effects of captopril therapy on cystine excretion in cystinuria. The individual case study performed by Dahlberg and Jones demonstrates a close correlation between urinary cystine determinations as quantitated both by the ion exchange–triketohydrindene hydrate (Ninhydrin) method and the phosphotungstic method that we used. The reason for the discrepancy between their results and those we obtained is unclear. As suggested by these authors, both the excretion of cystine and the effect of a vasoactive drug such as captopril on that excretion is probably multifactorial. Genetic subtypes of cystinuria could account not only for differing renal tubular handling of cystine, dibasic amino acid, and, possibly, captopril, but also for intestinal transport of these substances.2 Alternatively, their patient, who had such high levels of urinary cystine, may not have received enough captopril toThis publication has 2 references indexed in Scilit:
- Segmental effects of norepinephrine and angiotensin II on isolated renal microvesselsAmerican Journal of Physiology-Renal Physiology, 1983
- Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat.Circulation Research, 1975